Hindustan Laboratories, a generic drug maker, is preparing for its initial public offering. The company plans to raise funds through a fresh issue of shares and an offer for sale by its promoter. Proceeds will support working capital and general corporate needs. Hindustan Laboratories manufactures and supplies generic medicines to government institutions across India.